This is a Validated Antibody Database (VAD) review about human C3AR1, based on 3 published articles (read how Labome selects the articles), using C3AR1 antibody in all methods. It is aimed to help Labome visitors find the most suited C3AR1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
C3AR1 synonym: AZ3B; C3AR; HNFAG09

Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (D-12)
  • western blot knockout validation; human; 1:200; loading ...; fig 3b
Santa Cruz Biotechnology C3AR1 antibody (Santa Cruz, SC-133172) was used in western blot knockout validation on human samples at 1:200 (fig 3b). Nat Commun (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (D-12)
  • western blot; rat; 1:500; loading ...; fig 4b
Santa Cruz Biotechnology C3AR1 antibody (Santa Cruz, sc-133172) was used in western blot on rat samples at 1:500 (fig 4b). Theranostics (2020) ncbi
mouse monoclonal (D-12)
  • western blot knockout validation; human; 1:200; loading ...; fig 3b
Santa Cruz Biotechnology C3AR1 antibody (Santa Cruz, SC-133172) was used in western blot knockout validation on human samples at 1:200 (fig 3b). Nat Commun (2017) ncbi
BioLegend
mouse monoclonal (hC3aRZ8)
  • flow cytometry; human; fig s4g
BioLegend C3AR1 antibody (BioLegend, 345805) was used in flow cytometry on human samples (fig s4g). Cell Death Differ (2019) ncbi
Articles Reviewed
  1. Zhang L, Pan J, Mamtilahun M, Zhu Y, Wang L, Venkatesh A, et al. Microglia exacerbate white matter injury via complement C3/C3aR pathway after hypoperfusion. Theranostics. 2020;10:74-90 pubmed publisher
  2. Fauster A, Rebsamen M, Willmann K, César Razquin A, Girardi E, Bigenzahn J, et al. Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking. Cell Death Differ. 2019;26:1138-1155 pubmed publisher
  3. Lohman R, Hamidon J, Reid R, Rowley J, Yau M, Halili M, et al. Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a. Nat Commun. 2017;8:351 pubmed publisher